Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new information and a recommendation on hydroxychloroquine. It follows the publication of six trials synthesized in a living network meta-analysis (NMA).
A message from the partners of the Strategic Purchasing Africa
Resource Center (SPARC)
Since 2018, The Strategic Purchasing Africa Resource Center (SPARC) has been a unique and significant force in supporting countries within Sub-Sahara Africa (SSA) in crucial areas of strategic health purchasing (SHP), Healthcare Financing as they make progress towards the realization of Universal Health Coverage (UHC) goals. This initiative, a collaboration between Amref Health Africa and Results for Development (R4D), has made expertise in these areas more accessible and has been instrumental in the progress of the target countries. The initiative was designed to advance policy discussions and actions that strengthen the application of strategic health purchasing to strengthen African health systems and support countries as they address foundational reforms…